Optimi Health (XCNQ:OPTI) Short-Term Debt : C$0.00 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Optimi Health Short-Term Debt?

Optimi Health's Short-Term Debt for the quarter that ended in Dec. 2023 was C$0.00 Mil.

Optimi Health Short-Term Debt Historical Data

The historical data trend for Optimi Health's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimi Health Short-Term Debt Chart

Optimi Health Annual Data

Trend

Sep20

Sep21

Sep22

Sep23

Short-Term Debt

Optimi Health Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Short-Term Debt	Get a 7-Day Free Trial								-	-	-	-	-

Optimi Health Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Optimi Health Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Optimi Health's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Optimi Health (XCNQ:OPTI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimi Health Corp (XCNQ:OPTI) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

OPTHF:USA 8BN:Germany

Address

1122 Mainland Street, Suite 330, Vancouver, BC, CAN, V6B 5L1

Website

https://www.optimihealth.ca

Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing and distribution of agrifoods. It also intends to cultivate, extract, process and distribute high-quality strains of fungi products at its facilities located in Princeton, British Columbia.

Executives